Clinical Trial Update: Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Sofosbuvir/Velpatasvir fixed-dose combination in liver transplant recipients with chronic hepatitis C; study completed with posted resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Sofosbuvir/Velpatasvir (sofosbuvir/velpatasvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus Infection | Phase 2 | Status: COMPLETED | Results posted: 2018-08-21